Ava P. Amini
Ava P. Amini
Other namesAva P. Soleimany, Ava Soleimany, Ava Amini
Microsoft Research
Verified email at - Homepage
Cited by
Cited by
Renal clearable catalytic gold nanoclusters for in vivo disease monitoring
CN Loynachan*, AP Soleimany*, JS Dudani, Y Lin, A Najer, A Bekdemir, ...
Nature Nanotechnology, 1-8, 2019
Synthetic recombinase-based state machines in living cells
N Roquet, AP Soleimany, AC Ferris, S Aaronson, TK Lu
Science 353 (6297), aad8559, 2016
Deep evidential regression
A Amini, W Schwarting, A Soleimany, D Rus
Advances in Neural Information Processing Systems (NeurIPS) 33, 2020
Uncovering and mitigating algorithmic bias through learned latent structure
A Amini*, AP Soleimany*, W Schwarting, SN Bhatia, D Rus
AAAI/ACM Conference on Artificial Intelligence, Ethics, and Society, 2019
Synthetic and living micropropellers for convection-enhanced nanoparticle transport
S Schuerle, AP Soleimany, T Yeh, GM Anand, M Häberli, HE Fleming, ...
Science advances 5 (4), eaav4803, 2019
Evidential deep learning for guided molecular property prediction and discovery
AP Soleimany, A Amini, S Goldman, D Rus, SN Bhatia, CW Coley
ACS central science 7 (8), 1356-1367, 2021
Introduction to Deep Learning: MIT 6.S191
A Amini, A Soleimany
MIT, 2018
Activity-based diagnostics: an emerging paradigm for disease detection and monitoring
AP Soleimany, SN Bhatia
Trends in molecular medicine 26 (5), 450-468, 2020
Urinary detection of lung cancer in mice via noninvasive pulmonary protease profiling
JD Kirkpatrick*, AD Warren*, AP Soleimany*, PMK Westcott, JC Voog, ...
Science Translational Medicine 12 (537), 2020
Spatial uncertainty sampling for end-to-end control
A Amini, A Soleimany, S Karaman, D Rus
Neural Information Processing Systems (NeurIPS), 2017
Pharmacokinetic tuning of protein–antigen fusions enhances the immunogenicity of T-cell vaccines
NK Mehta, RV Pradhan, AP Soleimany, KD Moynihan, AM Rothschilds, ...
Nature Biomedical Engineering, 1-13, 2020
Protein structure generation via folding diffusion
KE Wu, KK Yang, R Berg, JY Zou, AX Lu, AP Amini
arXiv preprint arXiv:2209.15611, 2022
Activatable zymography probes enable in situ localization of protease dysregulation in cancer
AP Soleimany*, JD Kirkpatrick*, S Su, JS Dudani, Q Zhong, A Bekdemir, ...
Cancer Research 81 (1), 213-224, 2021
Genetic encoding of targeted MRI contrast agents for tumor imaging
S Schuerle, M Furubayashi, AP Soleimany, T Gwisai, W Huang, CA Voigt, ...
ACS Synthetic Biology, 2020
Low protease activity in B cell follicles promotes retention of intact antigens after immunization
A Aung, A Cui, L Maiorino, AP Amini, JR Gregory, M Bukenya, Y Zhang, ...
Science 379 (6630), eabn8934, 2023
Single-cell digital lysates generated by phase-switch microfluidic device reveal transcriptome perturbation of cell cycle
Y Chen, J Millstein, Y Liu, GY Chen, X Chen, A Stucky, C Qu, JB Fan, ...
ACS nano 12 (5), 4687-4694, 2018
Multiscale profiling of protease activity in cancer
AP Amini, JD Kirkpatrick, CS Wang, AM Jaeger, S Su, S Naranjo, Q Zhong, ...
Nature Communications 13 (1), 5745, 2022
Ionic Liquid‐Mediated Transdermal Delivery of Thrombosis‐Detecting Nanosensors
A Bekdemir, EEL Tanner, J Kirkpatrick, AP Soleimany, S Mitragotri, ...
Advanced Healthcare Materials 11 (11), 2102685, 2022
Protease activity sensors enable real-time treatment response monitoring in lymphangioleiomyomatosis
JD Kirkpatrick, AP Soleimany, JS Dudani, HJ Liu, HC Lam, C Priolo, ...
European Respiratory Journal 59 (4), 2022
Renal clearable nanocatalysts for disease monitoring
SN Bhatia, MM Stevens, C Loynachan, A Soleimany
US Patent App. 16/654,572, 2020
The system can't perform the operation now. Try again later.
Articles 1–20